Evidence map›Paper›PMID 32287312›Full record

ArticlePloS one2020

Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors.

Blanca Elena Castro-Magdonel, Manuela Orjuela, Diana E Alvarez-Suarez, Javier Camacho, Lourdes Cabrera-Muñoz, Stanislaw Sadowinski-Pine, Aurora Medina-Sanson, Citlali Lara-Molina, Daphne García-Vega, Yolanda Vázquez and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Potential Regulation ofInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Salivary Exosomes in Health and Disease: Future Prospects in the Eye.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Blanca Elena Castro-MagdonelMedical Research Unit in Infectious Diseases, Hospital de Pediatría, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Manuela OrjuelaEpidemiology Department, Columbia University, New York, New York, United States of America.
Diana E Alvarez-SuarezMedical Research Unit in Infectious Diseases, Hospital de Pediatría, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Javier CamachoPharmacology Department, CINVESTAV, Mexico City, Mexico.
Lourdes Cabrera-MuñozPathology Department, Hospital Infantil de Mexico Federico Gómez, Secretaría de Salud, Mexico City, Mexico.
Stanislaw Sadowinski-PinePathology Department, Hospital Infantil de Mexico Federico Gómez, Secretaría de Salud, Mexico City, Mexico.
Aurora Medina-SansonOncology Department, Hospital Infantil de México Federico Gómez, Secretaría de Salud, Mexico City, Mexico.
Citlali Lara-MolinaOphtalmology Department, Hospital Infantil de Mexico Federico Gómez, Secretaría de Salud, Mexico City, Mexico.
Daphne García-VegaOphtalmology Department, Hospital de Pediatría Silvestre Frenk, CMN SXXI, IMSS, Mexico City, Mexico.
Yolanda VázquezOphtalmology Department, Hospital de Pediatría Silvestre Frenk, CMN SXXI, IMSS, Mexico City, Mexico.
Noé Durán-FigueroaUnidad Profesional Interdisciplinaria de Biotecnología, Instituto Politécnico Nacional, Mexico City, Mexico.
María de Jesús Orozco-RomeroUnidad Profesional Interdisciplinaria de Biotecnología, Instituto Politécnico Nacional, Mexico City, Mexico.
Adriana Hernández-ÁngelesMedical Research Unit in Infectious Diseases, Hospital de Pediatría, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
M Verónica Ponce-CastañedaMedical Research Unit in Infectious Diseases, Hospital de Pediatría, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.ORCID 0000-0001-5076-1930
Mexican Social Security Institute · MXSecretaria de Salud · MXInstituto Politécnico Nacional · MXCentro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXColumbia University · US

Funding

Folate Deficiency, Metabolism &Sporadic RetinoblastomaR01CA098180 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ORJUELA, MANUELA A · 2003 to 2006
$2.0M
Methylation and mutations in RB1 and variants of synthetic folic acid metabolismR01CA192662 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ORJUELA, MANUELA A · 2015 to 2018
$1.5M
Unmetabolized folic acid and retinoblastoma.R21CA167833 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ORJUELA, MANUELA A · 2013 to 2014
$391k
NCI NIH HHS R01 CA098180NCI NIH HHS R01 CA192662NCI NIH HHS R21 CA167833
6 · The paper itself

Abstract

miRNAs regulate post-transcriptional gene expression in metazoans, and thus are involved in many fundamental cellular biological processes. Extracellular miRNAs are also found in most human biofluids including plasma. These circulating miRNAs constitute a long distance inter cellular communication system and are potentially useful biomarkers. High throughput technologies like microarrays are able to scan a complete miRNome providing useful detection scores that are underexplored. We proposed to answer how many and which miRNAs are detectable in plasma or extracellular vesicles as these questions have not yet been answered. We set out to address this knowledge gap by analyzing the mirRNome in plasma and corresponding extracellular vesicles (EVs) from 12 children affected by retinoblastoma (Rb) a childhood intraocular malignant tumor, as well as from 12 healthy similarly aged controls. We calculated an average of 537 detectable miRNAs in plasma and 625 in EVs. The most miRNA enriched compartment were EVs from Rb cases with an average of 656 detectable elements. Using hierarchical clustering with the detection scores, we generated broad detection mirnome maps and identified a plasma signature of 19 miRNAs present in all Rb cases that is able to discriminate cases from controls. An additional 9 miRNAs were detected in all the samples; within this group, miRNA-5787 and miRNA-6732-5p were highly abundant and displayed very low variance across all the samples, suggesting both are good candidates to serve as plasma references or normalizers. Further exploration considering participant's sex, allowed discovering 5 miRNAs which corresponded only to females and 4 miRNAs corresponding only to males. Target and pathway analysis of these miRNAs revealed hormonal function including estrogen, thyroid signaling pathways and testosterone biosynthesis. This approach allows a comprehensive unbiased survey of a circulating miRNome landscape, creating the possibility to define normality in mirnomic profiles, and to locate where in these miRNome profiles promising and potentially useful circulating miRNA signatures can be found.

Indexed as

Biomarkers, TumorCase-Control StudiesChild, PreschoolCirculating MicroRNACluster AnalysisDiscriminant AnalysisExtracellular VesiclesFemaleHumansInfantMaleMicroRNAsOligonucleotide Array Sequence AnalysisRetinal NeoplasmsRetinoblastomaBiomarkers, TumorCirculating MicroRNAMicroRNAs

Identifiers

PMID32287312
PMCPMC7156076
OpenAlexW3015363404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.